baber/WOPTO huggingface dataset:
Patent CH-715522-B1 (CH)
Title: Émerillon à partie souple.
Inventor: JACQUES CHRISTINET
IPC: F16G15/08
Filed: 2018-11-07
Abstract: L'invention concerne un émerillon comprenant une chambre de rotation (2), un dispositif de maintien (3), par exemple un axe, tournant librement dans la chambre de rotation, et une partie en matière souple (5), comme un textile en matière synthétique ou métallique, maintenue par le dispositif de maintien.
Patent CH-713074-B1 (CH)
Title: Mouvement d'horlogerie comportant deux affichages analogiques opposés.
Inventor: WALTER SCHLUP
IPC: G04B19/23
Filed: 2016-10-25
Abstract: Le mouvement d'horlogerie de l'invention, de type conventionnel à barillet (10) et balancier- spiral, comporte deux affichages de l'heure à aiguilles, les aiguilles (3h, 3m, 3s) de l'un des affichages, disposées en regard de l'une des faces principales (1) du mouvement, étant entraînées en rotation de manière connue par un train d'engrenages comprenant une roue dentée moyenne (16) fixée sur un arbre (51) avec un pignon (15) mis en rotation par le barillet par l'intermédiaire d'une roue dentée grande moyenne (12). En regard de l'autre face principale (2) se trouve un autre affichage de l'heure dont les aiguilles (5h, 5m) sont entraînées par un autre train d'engrenages (53, 54, 56, 57, 58, 59, 60, 61) dont un pignon (53) est fixé sur l'arbre (51) de la roue moyenne (16) pour entraîner en rotation les autres mobiles. Cette disposition est avantageuse pour permettre la transformation d'un mouvement existant à un seul affichage en un mouvement à deux affichages opposés. Dans une réalisation, le ressort du barillet (10) est armé par un dispositif de remontage automatique comprenant une masse oscillante (7) disposée de l'autre face principale (2) du mouvement. Deux tiges de mise à l'heure (6, 6') permettent de corriger chaque affichage indépendamment de l'autre.
Patent CH-710444-B1 (CH)
Title: Bassin avec installation de traitement d'eau à l'ozone.
Inventor: JOHN PAYAGE
IPC: E04H4/16
Filed: 2014-12-03
Abstract: L’invention a pour objet un bassin (1) muni d’une installation de traitement d’eau (6, 7, 8), comprenant un générateur d’ozone (6), agencé pour générer de l’ozone et pour injecter dans le bassin une eau traitée pauvre en ozone et, par intermittence, une eau riche en ozone pour un traitement bactériologique de l’eau dans le bassin. Le bassin est muni d’une pluralité de buses (2) pour l’injection simultanée d’eau riche en ozone en plusieurs points du bassin (1), notamment pour homogénéiser la distribution de l’ozone au sein du bassin.
Patent CH-709004-B1 (CH)
Title: Tragbare mobile Toilette.
Inventor: MARCEL ECK
IPC: E03D7/00
Filed: 2013-12-19
Abstract: Die tragbare und mobile Toilette (1) eignet sich für Mann und Frau und umfasst einen mobilen ersten Behälter (5), in welchem Urin (21) gesammelt wird und im ersten Behälter (5) integriert einen zweiten Behälter (7), in welchem die festen Fäkalien gesammelt werden. Mit einem Schlauch (29) kann aus einer Flasche (35) oder einem anderen flexiblen Behälter (35) Wasser zum Duschen des Analbereichs zu diesem geleitet werden.
Patent EP-1034864-B1 (EP)
Inventor: DREPS KLAUS
IPC: B23B51/02
Filed: 2000-03-03
Granted: 2004-12-22
Abstract: The drill has the slit in its tip in which a hard metal plate (10) is anchored. The plate has a conic edge (20) on the top with an angle of 130 deg and a protruding central hard metal tip (12) which accommodates a main cutting surface (14). A secondary cutting surface (16) is provided in the lower part of the slope of the conic edge.
Patent EP-1068983-B1 (EP)
Inventor: HALLAS ERNST O DR
IPC: B60R11/02
Filed: 2000-07-05
Granted: 2006-08-09
Abstract: The communications device has a number of individual components which are located at different points within the automobile and coupled together via a bus (B), with management of the bus via a microcomputer incorporated in an operating device (1) fitted in the automobile dashboard. The operating device has mechanical and electrical interfaces and a locking/unlocking device for facilitating its removal.
Patent EP-1069153-B1 (EP)
Inventor: SUDO MORIHIRO
IPC: C08J7/02
Filed: 2000-07-11
Granted: 2005-07-27
Abstract: Rubber plugs, which are to be used with medical containers or medical devices, are produced by forming a vulcanizable, mixed rubber compound, vulcanizing a resultant formed rubber compound, treating the rubber plug with steam of high temperature and high pressure, treating the rubber plugs in an aqueous solution which has been adjusted to be acidic, rinsing the rubber plugs with high-quality water, washing the rubber plugs with a shower of dust- and germ-free water, and drying the rubber plugs by at least one of far infrared radiation and high frequency heating. The process makes it possible to reduce the number of insoluble fine particles, which are attracted on a surface of each rubber plug, to an extremely low level and moreover, remove (or deactivate) pyrogen substances on and in the vicinity of the surface of the rubber plug.
Patent EP-1072896-B1 (EP)
Inventor: EBERT VOLKER
IPC: G01K7/20
Filed: 2000-07-18
Granted: 2009-06-17
Abstract: In the internal circuit (20), variable resistance (RT) is switched (S) to earth, at the same time shorting a known resistance (R2) in parallel with the switch, to earth, which is used as a reference potential. A condenser (C) is connected in parallel with the circuit comprising the variable resistance in series with the switch, and the known resistance in parallel with the switch. Voltage drop (U0) across variable resistance (R2) and that (U1) across the known resistance are only measured with the switch opened. The value of the variable resistance is evaluated using this relationship: RT = R2 . ((U0 - U1) / U1).
Patent EP-1150627-B1 (EP)
Inventor: NIELSEN INGER MANN
IPC: A61F5/445
Filed: 2000-02-10
Granted: 2004-04-07
Abstract: A disposable closure for a natural or artificial intestinal or urethral opening in the form of a body made from a material being soluble in visceral contents provides a disposable closure for a natural or artificial intestinal or urethral opening which closure is easy to apply, provides a proper sealing and is readily removed after having exercised its effect.
Patent EP-1147208-B1 (EP)
Inventor: BARSKY SANFORD H
IPC: A61K38/57
Filed: 2000-01-20
Granted: 2006-12-13
Abstract: The present invention provides methods for the selective transduction of a cell in a ductal system in a mammary gland by contacting, via ductal cannulation, the cell with a vector that selectively targets the cell. In this context, the invention provides prophylactic and therapeutic methods of treating the ductal epithelium of the breast, for disease, in particular cancer. The present invention further provides diagnostic methods of determining the presence of disease in the ductal epithelium of the breast, in particular cancer.
Patent EP-1161808-B1 (EP)
Inventor: BEMMER RENE
IPC: H04L1/00
Filed: 2000-03-13
Granted: 2005-07-27
Abstract: The invention concerns a procedure to adapt the operating mode of a multi-mode codec to the changing transmission conditions in a CDMA mobile transmission network. The object consists of the coordination of the adaption of the codec operating modes in both transmission interfaces involved. This is achieved by a constant polling regarding the quality of transmission on the transmission segments during a communication connection, where a change in transmission quality for any unit involved in the transmission initiates a change of codec operating modes and where the present or future change in codec operating mode is passed to the other units involved in the transmission.
Patent EP-1165786-B1 (EP)
Inventor: DENSHAM DANIEL HENRY
IPC: C12N15/54
Filed: 2000-04-06
Granted: 2008-07-09
Abstract: The present invention pertains to a method for polynucleotide synthesis, comprising the steps of: (i) reacting a polynucleotide processive enzyme, e.g., a polymerase or TdT, with a nucleotide substrate under conditions suitable for enzyme activity; and (ii) modulating the conformation of the enzyme, e.g. using radiation, to allow incorporation of a predetermined nucleotide.
Patent EP-1102061-B1 (EP)
Inventor: KOINUMA HIDEOMI
IPC: G01N23/207
Filed: 2000-05-22
Granted: 2009-04-01
Abstract: Cette invention se rapporte à un appareil de diffraction à rayons X combinatoire, en particulier un appareil de diffraction à rayons X combinatoire qui peut mesurer simultanément par diffraction de rayons X une rangée d'échantillons parmi plusieurs échantillons disposés selon un alignement matriciel. En vue de permettre un criblage de rendement élevé, plusieurs échantillons (10) sont disposés le long d'une rangée X1, une rangée X2, une rangée X3 et une rangée X4 sur un support porte-échantillons et les échantillons de chaque rangée sont mesurés simultanément par diffraction de rayons X, les données mesurées sont traitées par un processeur d'informations (20), les données d'informations utiles pour l'évaluation du matériau en film mince sont automatiquement extraites et agencées et les données d'informations ainsi extraites et agencées sont affichées sur une unité d'affichage (27).
Patent EP-1296672-B1 (EP)
Inventor: PFLAUM ZLATKO
IPC: A61K31/22
Filed: 2000-06-09
Granted: 2008-12-31
Abstract: Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used for the treatment of hypercholesterolemia and hyperlipidemia. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor or Penicillium genus, and some are obtained by treating the fermentation products using the methods of chemical synthesis or they are the products of total chemical synthesis. The aforementioned active substances may be destabilised by the environmental factors, their degradation may also be accelerated by interactions with other pharmaceutical ingredients, such as fillers, binders, lubricants, glidants and disintegrating agents, therefore the pharmaceutical ingredients and the process for preparation of the pharmaceutical formulation should be meticulously chosen to avoid the aforementioned undesired interactions and reactions. The present invention relates to a product or a pharmaceutical package or administration material which contains a HMG-CoA reductase inhibitor or a pharmaceutical formulation in a stable manner.
Patent EP-1185317-B1 (EP)
Inventor: JADHAV BALKRISHNA S
IPC: A61L31/06
Filed: 2000-06-02
Granted: 2005-05-04
Abstract: L'invention concerne un extenseur biocompatible et biorésorbable, conçu pour restaurer ou conserver la perméabilité après des interventions chirurgicales ou des blessures traumatiques ou après la formation d'une sténose. Cet extenseur se compose d'un mélange d'au moins deux polymères, que l'on extrude sous forme d'un monofilament que l'on tisse ensuite pour obtenir un matériau du type natté, ou que l'on moule par injection ou que l'on extrude sous forme d'un tube présentant des perforations dans sa paroi. L'invention concerne encore des procédés de fabrication de cet extenseur.
Patent EP-1105017-B1 (EP)
Inventor: OBERMANN WOLFGANG
IPC: A45D26/00
Filed: 2000-06-07
Granted: 2003-09-03
Abstract: A depilation system which comprises a depilation device and a cooling device and in which the cooling device comprises a housing in which a certain quantity of cooling agent is contained, and in which the cooling device is provided with a skin contact portion having a certain skin contact surface area, and in which the cooling device has a certain power for cooling skin regions through the skin contact portion (13), and in which the value of the power of the cooling device (3) is at least 3 W, the value of the quantity of cooling agent contained is at least 20 ml, and the value of the contact surface area of the skin contact portion (13) is at least 3 cm2.
Patent EP-1188180-B1 (EP)
Inventor: ANAND SRINIVASAN
IPC: H01L21/465
Filed: 2000-06-21
Granted: 2009-11-11
Abstract: A substrate whose elemental constituents are selected from Groups III and V of the Periodic Table, is provided with pre-defined masked regions. Etching of the substrate comprising the steps of: a) forming a gas containing molecules having at least one methyl group (CH<SUB>3</SUB>) linked to nitrogen into a plasma; and b) etching the unmasked regions of the substrate by means of the plasma. For a substrate whose elemental constituents are selected from Groups II and VI of the Periodic Table, the plasma etching gas used is trimethylamine. Since the methyl compound of nitrogen has a lower bond energy than for hydrocarbon mixtures, free methyl radicals are easier to obtain and the gas is more efficient as a methyl source. In addition, compared with hydrocarbon mixtures, reduced polymer formation can be expected due to preferential formation of methyl radicals over polymer-generating hydrocarbon radicals because of the lower bond energy for the former.
Patent EP-1242059-B1 (EP)
Inventor: BOYKIN DAVID W
IPC: A61K47/48
Filed: 2000-07-06
Granted: 2007-03-21
Abstract: A methods of treating an infection comprises administering a therapeutically effective amount of a compound described by the Formula (I)
Patent EP-1218676-B1 (EP)
Inventor: AGERGAARD POVL
IPC: F25B43/00
Filed: 2000-09-07
Granted: 2004-07-07
Abstract: A refrigerator comprising evaporator (1), cyclone separator (21), and supply pipe (8) between condensator and evaporator (1). The evaporator (1) is connected to an upper part of the cyclone separator (21) via delivery pipe (3). The cyclone separator (21) is disposed at a distance above the evaporator (1). The lower part of the cyclone separator (21), which is a liquid collecting compartment, is connected to the evaporator (1) via a down pipe (10).
Patent EP-1224007-B1 (EP)
Inventor: SUN WEIMIN
IPC: A61N1/365
Filed: 2000-10-06
Granted: 2004-09-15
Abstract: Methods of adjusting output mapping in response to historical signal input data relative to a reference value, and apparatus to perform the methods. The methods are suited for use in adjusting rate-adaptive pacemakers in response to a patient's demonstrated activity relative to a predetermined activity level. The methods include using historical physiologic sensor input to derive a patient's activity. The methods further include tuning a rate-adaptive curve in response to a demonstrated exertion level and a demonstrated exertion time indicative of a breadth and frequency of a patient's activity above some reference value. Pacemakers adapted to perform the methods include a processor, at least one physiologic sensor, a variable-rate pulse generator and a memory for storing historical physiologic sensor data.
Patent EP-1218011-B1 (EP)
Inventor: BERNSTEIN LAWRENCE R
IPC: A61K33/24
Filed: 2000-10-04
Granted: 2007-01-10
Abstract: L'invention concerne des méthodes destinées au traitement ou à la prévention d'infections par des procaryotes intracellulaires obligatoires tels que le Mycoplasma, la Rickettsie et la Chlamydia, des rétrovirus et des virus à ADN, notamment les virus herpétiques, les papillomavirus, les adénovirus et le virus de l'hépatite B. L'accent est mis sur des méthodes destinées au traitement de l'infection à VIH. Outre ces méthodes de traitement de l'infection à VIH elle-même, l'invention concerne des méthodes de traitement d'un patient infecté par VIH souffrant d'une co-infection par un autre rétrovirus, un procaryote intracellulaire obligatoire ou un virus à ADN. Ces méthodes consistent à administrer des complexes de 3-hydroxy-4-pyrones en proportion 3:1 avec du gallium, par exemple du maltolate de gallium. L'invention concerne également des thérapies utilisant du maltolate de gallium en combinaison avec des agents utilisés contre des agents pathogènes tels que les procaryotes intracellulaires obligatoires, les rétrovirus et les virus à ADN. Elle concerne en outre des thérapies multicombinatoires conçues pour traiter une co-infection par un procaryote intracellulaire obligatoire, un rétrovirus ou un virus à ADN chez un individu infecté par VIH. Ces thérapies multicombinatoires reposent sur la capacité du maltolate de gallium à compléter des régimes médicamenteux antiviraux dirigés contre VIH et d'autres agents pathogènes, par exemple dans le cas d'infections à virus herpétique telles que le sarcome de Kaposi, la cécité et la rétinite à cytomégalovirus ou les lymphomes chez des patients immunodéprimés par l'infection à VIH.
Patent EP-1230437-B1 (EP)
Inventor: RAY SIBA P
IPC: C25C7/02
Filed: 2000-10-27
Granted: 2004-12-08
Abstract: An inert anode for the electrolytic production of metals such as aluminum is disclosed. The inert anode includes a ceramic oxide material preferably made from NiO, Fe2O3 and ZnO. The inert anode composition may comprise the following mole fractions of NiO, Fe2O3 and ZnO: 0.2 to 0.99 NiO; 0.0001 to 0.8 Fe2O3; and 0.0001 to 0.3 ZnO. The inert anode may optionally include other oxides and/or at least one metal phase, such as Cu, Ag, Pd, Pt, Au, Rh, Ru, Ir and/or Os. The Ni-Fe-Co-O ceramic material exhibits very low solubility in Hall cell baths used to produce aluminum.
Patent EP-1225817-B1 (EP)
Inventor: CARLSON J MARTIN
IPC: A43B17/02
Filed: 2000-11-01
Granted: 2006-08-23
Abstract: Le coussinet (10; 40; 64; 82; 94; 130; 140; 150) destiné à porter une partie du corps humain est constitué de deux couches pratiquement non élastiques ou non extensibles (12; 14; 44; 46; 62; 63; 141; 142; 151; 152) qui sont jointes ensemble le long d'un bord périphérique (16; 42; 65; 96) et puis dans des zones locales (18; 20A-20C; 67) de manière à former des capsules individuelles (24A-24F; 48A-48F; 49A-49F; 68A-68F; 70A-70F; 82A-82F; 84A-84F; 86A-86F; 88A-88F) dans le coussinet (10; 40; 64; 82; 94; 130; 140; 150). Les couches sont 'matelassées' dans les zones définies par les capsules (24A-24F; 48A-48F; 49A-49F; 68A-68F; 70A-70F; 82A-82F; 84A-84F; 86A-86F; 88A-88F) pour commander où et à quel point le coussinet peut se gonfler. Le coussinet (10; 40; 64; 82; 94; 130; 140; 150) est rempli d'une matière en cire qui est plastique mais ne s'écoule pas facilement. Des applications répétées de charges de cire (21 ; 126) permettent à la cire de s'écouler ou de migrer lentement afin de modifier l'aspect de la cire (21 ; 126) pour qu'elle prenne la forme de la surface en contact avec le coussinet (10; 40; 64; 82; 94; 130; 140; 150) et la porte.
Patent EP-1237918-B1 (EP)
Inventor: PORTEOUS DAVID
IPC: C07K14/47
Filed: 2000-11-28
Granted: 2010-04-14
Abstract: A newly identified gene, DIS1 is disrupted by a (1;11)(q42.1;q14.3) translocation which segregates with schizophrenia. We have examined the genomic structure of DIS1 and found that the gene consists of 13 exons estimated to extend across at least 300 kb of DNA. Exon 11 contains an alternative splice site which removes 66 nucleotides from the open reading frame. The final intron of DIS1 belongs to the rare AT-AC class of introns. 8 expressed sequence tags (ESTs) located within introns 3, 7, 9 and 10 of DIS1 have also been identified. These ESTs have not yet been assigned to DIS1 and may therefore represent further novel genes in the region.
Patent EP-1343595-B1 (EP)
Inventor: DAO VIET DUNG
IPC: B05C1/08
Filed: 2000-12-22
Granted: 2004-09-08
Abstract: The invention concerns a method for indirect thin-layer coating using an applicator roll (5) receiving the coating composition (3) partly immersed in a vessel or tank (1) containing the coating composition. The invention is characterised in that at the outlet of said vessel or tank (1), the emerging part of the applicator roll (5), in order to spread uniformly the coating composition, is in contact with a levelling roll (19) provided with a elastomer coat (21), rotating or not in the same direction as the applicator cylinder (5) and whereof the peripheral speed of rotation is different from that of the applicator roll (5). The invention is in particular useful for PVC or linoleum flooring or wall facing.
Patent EP-1155235-B1 (EP)
Inventor: VILOU GERARD
IPC: H01H47/04
Filed: 2000-12-08
Granted: 2005-03-02
Abstract: L'invention concerne un procédé d'alimentation d'un contacteur (10) de démarreur électrique de véhicule automobile dans lequel on fournit sur un circuit d'alimentation (T1, B, 20, 25) du contacteur (10) un signal d'alimentation efficace (R1, R2, R3) ayant une évolution choisie, caractérisé en ce qu'on fournit également, sur le circuit d'alimentation (T1, B, 20, 25), un signal supplémentaire (T, R4) ayant une forme choisie pour faciliter l'identification de l'évolution du signal d'alimentation efficace (R1, R2, R3).
Patent EP-1164707-B1 (EP)
Inventor: HAROUN BAHER S
IPC: H03M1/06
Filed: 2001-05-15
Granted: 2007-10-24
Abstract: An analog signal (VIN) is converted into a digital signal (24) by sampling the analog signal at a plurality of points in time to produce a sampled signal (32) which represents the analog signal. A filtering operation is advantageously incorporated into the sampling operation (102) . The filtering operation filters the analog signal such that the sampled signal represents a filtered version of the analog signal. The digital signal is produced from the sampled signal. <IMAGE>
Patent EP-1132195-B1 (EP)
Inventor: KUCKERTZ CHRISTIAN DR
IPC: B05D3/14
Filed: 2001-02-23
Granted: 2008-01-09
Abstract: The plasmatron provides homogenous treatment or coating, over an entire or partial surface, of a band of metallic material with a thickness less than 100 mu m, or of a band of polymer material Preferred features: The indirect plasmatron has a lengthy plasma chamber with a series of mutually-insulated neutrodes. Electrodes required to produce the plasma arc gas are coaxial with the longitudinal axis. The plasma jet outlet opening is parallel to the axis. Neutrodes are associated with permanent magnet pairs, influencing form and location of the plasma arc. A gas and/or aerosol can be supplied into the plasma chamber. This leaves in the jet, and reacts with the metallic- or plastic surface of the feeedstock. The polymer film is vapor-deposited with metal, metal oxide or SiO2. In conjunction with an inert gas, in gaseous or aerosol form, an oxidant, polymerizing material or graft copolymer may be supplied. The feedstock velocity is 1-600 m per minute. The atmospheric plasma acts upon it at a distance of 0-40 mm.
Patent EP-1110874-B1 (EP)
Inventor: DUBS HANS DIETER
IPC: B65D51/16
Filed: 1998-06-17
Granted: 2003-04-02
Abstract: On the base(3) of the closure there is a sealing insert(9) with a ring area(11) which lies against the container edge and has a compression zone(13). The ring area includes one or more radial grooves extending from the central area(19) of the insert to the compression zone. An Independent claim is made for a tool for producing the container closure comprising a punch and a surrounding collar. The punch face facing the base(3) of the closure has a peripheral recess and/or peripheral raised area projection facing the ring area(11) of the sealing insert(9) and an annular groove with ribs to form the radial grooves in the closure.
Patent EP-1136189-B1 (EP)
Inventor: DEIMEL THOMAS
IPC: B25D9/26
Filed: 2001-03-10
Granted: 2004-05-12
Abstract: The hammer mechanism is arranged so that the striking piston (3) is made immobile if in normal operation (long or short stroke) the run-out setting in the working stroke direction (3e) has overrun a set part of its travel up to adopting an idling stroke setting. The cavity of the working cylinder (2) also has an idling stroke inlet (20a).